Impact Biomedical (IBO) Ending Cash Balance (2022 - 2026)
Impact Biomedical's Ending Cash Balance came in at $21,000 for Q3 2026, up 75.0% from $12,000 a year earlier and up 110.0% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Ending Cash Balance (2022 - 2026) Analysis & Trends
For FY2025, Impact Biomedical's Ending Cash Balance was $3,000, down 99.8% from FY2024.
- Ending Cash Balance carries a three-year compound annual growth rate of 14.5% (FY2022 to FY2025).
- Going back by year, Ending Cash Balance was $2 million in FY2024, $1,000 in FY2023 (-50.0%) and $2,000 in FY2022.
- The Q3 2026 figure represents the highest quarterly Ending Cash Balance since Q2 2025.
- Year-over-year, Ending Cash Balance increased in 1 of the last five quarters, with an average decline of 64.3%.
- The fastest year-over-year change in Ending Cash Balance over five years came in Q1 2024 (growth of 100.0%), and the weakest in Q4 2025 (a decline of 99.8%).
- Business Quant data shows IBO's Ending Cash Balance at $10,000 (Q2 2026), $20,000 (Q1 2026) and $3,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | 21,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21,000.00 |
| Jun 30, 2026 | 10,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 624,000.00 |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 131,000.00 |
API Access
Impact Biomedical Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();